Abstract |
Death associated protein kinase (DAPK) is a calcium and calmodulin regulated enzyme that functions early in eukaryotic programmed cell death, or apoptosis. To validate DAPK as a potential drug discovery target for acute brain injury, the first small molecule DAPK inhibitor was synthesized and tested in vivo. A single injection of the aminopyridazine-based inhibitor administered 6 h after injury attenuated brain tissue or neuronal biomarker loss measured, respectively, 1 week and 3 days later. Because aminopyridazine is a privileged structure in neuropharmacology, we determined the high-resolution crystal structure of a binary complex between the kinase domain and a molecular fragment of the DAPK inhibitor. The co-crystal structure describes a structural basis for interaction and provides a firm foundation for structure-assisted design of lead compounds with appropriate molecular properties for future drug development.
|
Authors | Anastasia V Velentza, Mark S Wainwright, Magdalena Zasadzki, Salida Mirzoeva, Andrew M Schumacher, Jacques Haiech, Pamela J Focia, Martin Egli, D Martin Watterson |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 13
Issue 20
Pg. 3465-70
(Oct 20 2003)
ISSN: 0960-894X [Print] England |
PMID | 14505650
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Apoptosis Regulatory Proteins
- Enzyme Inhibitors
- Pyridazines
- pyridazine
- Death-Associated Protein Kinases
- Calcium-Calmodulin-Dependent Protein Kinases
|
Topics |
- Animals
- Apoptosis
- Apoptosis Regulatory Proteins
- Brain Injuries
(etiology, prevention & control)
- Calcium-Calmodulin-Dependent Protein Kinases
(antagonists & inhibitors)
- Death-Associated Protein Kinases
- Enzyme Inhibitors
(chemistry, pharmacology)
- Hypoxia-Ischemia, Brain
(complications, prevention & control)
- Mice
- Pyridazines
(chemistry, pharmacology)
|